The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle

Physiological Reports

Volumn 3, Issue 8, 2015, Pages

  Hjorth, Marit ^a   Norheim, Frode ^a   Meen, Astri J ^a   Pourteymour, Shirin ^a   Lee, Sindre ^a   Holen, Torgeir ^a   Jensen, Jørgen ^b   Birkeland, Kåre I ^c   Martinov, Vladimir N ^a   Langleite, Torgrim M ^a,c   Eckardt, Kristin ^a   Drevon, Christian A ^a   Kolset, Svein O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Extracellular matrix; Physical activity; Proteoglycan; Serglycin; Serpin E1

Indexed keywords

AGGRECANASE 1; AGRIN; BIGLYCAN; COLLAGEN TYPE 1 ALPHA 1; COLLAGEN TYPE 3 ALPHA 1; COLLAGEN TYPE 4 ALPHA 1; DECORIN; GLYPICAN 3; HEAT SHOCK PROTEIN 47; HEPARAN SULFATE PROTEOGLYCAN 2; HERMES ANTIGEN; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN 3; KIELIN CHORDIN LIKE PROTEIN; LAMININ SUBUNIT BETA 1; LAMININ SUBUNIT GAMMA 3; LYSYL OXIDASE LIKE 3; MATRIX METALLOPROTEINASE 14; NIDOGEN 1; OSTEONECTIN; PEPTIDES AND PROTEINS; PERLECAN; PROTEOGLYCAN; SCLEROPROTEIN; SEMAPHORIN; SERGLYCIN; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 2; SYNDECAN 4; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; GENE SILENCING; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SKELETAL MUSCLE;

EID: 85005992587     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12473     Document Type: Article

References (80)

1. Abrink, M., M. Grujic, and G. Pejler. 2004. Serglycin is essential for maturation of mast cell secretory granule. J. Biol. Chem. 279:40897-40905.
2. American College of Sports Medicine. 2013. ACSM’s guidelines for exercise testing and prescription. Lippincott Williams & Wilkins, Baltimore, MD.
3. Andrade, W., and E. Brandan. 1991. Isolation and characterization of rat skeletal muscle proteoglycan decorin and comparison with the human fibroblast decorin. Comp. Biochem. Physiol. B 100:565-570.
4. Baghy, K., R. V. Iozzo, and I. Kovalszky. 2012. Decorin-TGFbeta axis in hepatic fibrosis and cirrhosis. J. Histochem. Cytochem. 60:262-268.
5. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57:289-300.
6. Berria, R., L. Wang, D. K. Richardson, J. Finlayson, R. Belfort, T. Pratipanawatr, et al. 2006. Increased collagen content in insulin-resistant skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 290:E560-E565.
7. Blaauw, B., and C. Reggiani. 2014. The role of satellite cells in muscle hypertrophy. J. Muscle Res. Cell Motil. 35:3-10.
8. Brandan, E., and J. Gutierrez. 2013a. Role of proteoglycans in the regulation of the skeletal muscle fibrotic response. FEBS J. 280:4109-4117.
9. Brandan, E., and J. Gutierrez. 2013b. Role of skeletal muscle proteoglycans during myogenesis. Matrix Biol. 32:289-297.
10. Catoire, M., and S. Kersten. 2015. The search for exercise factors in humans. FASEB J. 29:1615-1628.
11. Colberg, S. R., R. J. Sigal, B. Fernhall, J. G. Regensteiner, B. J. Blissmer, R. R. Rubin, et al. 2010. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 33:2692-2696.
12. Cornelison, D., M. S. Filla, H. M. Stanley, A. C. Rapraeger, and B. B. Olwin. 2001. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev. Biol. 239:79-94.
13. Eckardt, K., S. W. Gorgens, S. Raschke, and J. Eckel. 2014. Myokines in insulin resistance and type 2 diabetes. Diabetologia 57:1087-1099.
14. Egan, B., and J. R. Zierath. 2013. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 17:162-184.
15. Esko, J. D., and S. B. Selleck. 2002. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71:435-471.
16. Frost, R. A., G. J. Nystrom, and C. H. Lang. 2006. Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290:R773-R784.
17. Gandhi, N. S., and R. L. Mancera. 2008. The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug Des. 72:455-482.
18. Ghosh, A. K., and D. E. Vaughan. 2012. PAI-1 in tissue fibrosis. J. Cell. Physiol. 227:493-507.
19. Gillies, A. R., and R. L. Lieber. 2011. Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve 44:318-331.
20. Golbidi, S., and I. Laher. 2014. Exercise induced adipokine changes and the metabolic syndrome. J. Diabetes Res. 2014:726861.
21. Goody, M. F., R. B. Sher, and C. A. Henry. 2015. Hanging on for the ride: adhesion to the extracellular matrix mediates cellular responses in skeletal muscle morphogenesis and disease. Dev. Biol. 401:75-91.
22. Gramling, M. W., and F. C. Church. 2010. Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment. Thromb. Res. 125:377-381.
23. Grujic, M., T. Braga, A. Lukinius, M. L. Eloranta, S. D. Knight, G. Pejler, et al. 2005. Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage. J. Biol. Chem. 280:33411-33418.
24. Gustafsson, T. 2011. Vascular remodelling in human skeletal muscle. Biochem. Soc. Trans. 39:1628-1632.
25. Haas, T., M. Milkiewicz, S. Davis, A. Zhou, S. Egginton, M. Brown, et al. 2000. Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 279:H1540-H1547.
26. Haugen, F., F. Norheim, H. Lian, A. J. Wensaas, S. Dueland, O. Berg, et al. 2010. IL-7 is expressed and secreted by human skeletal muscle cells. Am. J. Physiol. Cell Physiol. 298:C807-C816.
27. Hittel, D. S., W. E. Kraus, and E. P. Hoffman. 2003. Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndrome. J. Physiol. 548:401-410.
28. Humphrey, J. D., E. R. Dufresne, and M. A. Schwartz. 2014. Mechanotransduction and extracellular matrix homeostasis. Nat. Rev. Mol. Cell Biol. 15:802-812.
29. Hynes, R. O. 2009. The extracellular matrix: not just pretty fibrils. Science 326:1216-1219.
30. Imoto-Tsubakimoto, H., T. Takahashi, T. Ueyama, T. Ogata, A. Adachi, N. Nakanishi, et al. 2013. Serglycin is a novel adipocytokine highly expressed in epicardial adipose tissue. Biochem. Biophys. Res. Commun. 432:105-110.
31. Kang, L., J. E. Ayala, R. S. Lee-Young, Z. Zhang, F. D. James, P. D. Neufer, et al. 2011. Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin a2b1 in mice. Diabetes 60:416-426.
32. Kanzleiter, T., M. Rath, S. W. Gorgens, J. Jensen, D. S. Tangen, A. J. Kolnes, et al. 2014. The myokine decorin is regulated by contraction and involved in muscle hypertrophy. Biochem. Biophys. Res. Commun. 450:1089-1094.
33. Kim, D., G. Pertea, C. Trapnell, H. Pimentel, R. Kelley, and S. L. Salzberg. 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14:R36.
34. Kjaer, M. 2004. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol. Rev. 84:649-698.
35. Koh, T. J., S. C. Bryer, A. M. Pucci, and T. H. Sisson. 2005. Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. Am. J. Physiol. Cell Physiol. 289:C217-C223.
36. Kolset, S. O., and G. Pejler. 2011. Serglycin: a structural and functional chameleon with wide impact on immune cells. J. Immunol. 187:4927-4933.
37. Kolset, S. O., and L. Zernichow. 2008. Serglycin and secretion in human monocytes. Glycoconj. J. 25:305-311.
38. Kolset, S. O., K. Prydz, K. Fjeldstad, F. Safaiyan, T. T. Vuong, E. Gottfridsson, et al. 2002. Effect of brefeldin A on heparan sulphate biosynthesis in Madin-Darby canine kidney cells. Biochem. J. 362:359-366.
39. Kolset, S. O., K. Prydz, and G. Pejler. 2004. Intracellular proteoglycans. Biochem. J. 379:217-227.
40. Kolset, S. O., F. P. Reinholt, and T. Jenssen. 2012. Diabetic nephropathy and extracellular matrix. J. Histochem. Cytochem. 60:976-986.
41. Kolseth, I., T. Reine, T. Vuong, A. Meen, Q. Fan, T. Jenssen, et al. 2015. Serglycin is part of the secretory repertoire of LPS-activated monocytes. Immun. Inflamm. Dis. 3:23-31.
42. Korpetinou, A., S. S. Skandalis, V. T. Labropoulou, G. Smirlaki, A. Noulas, N. K. Karamanos, et al. 2014. Serglycin: at the crossroad of inflammation and malignancy. Front. Oncol. 3:327.
43. Kragstrup, T. W., M. Kjaer, and A. L. Mackey. 2011. Structural, biochemical, cellular, and functional changes in skeletal muscle extracellular matrix with aging. Scand. J. Med. Sci. Sports 21:749-757.
44. Kubota, S., and M. Takigawa. 2015. Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions. Clin. Sci. 128:181-196.
45. Langmead, B., C. Trapnell, M. Pop, and S. L. Salzberg. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10:R25.
46. Lecker, S. H., R. T. Jagoe, A. Gilbert, M. Gomes, V. Baracos, J. Bailey, et al. 2004. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18:39-51.
47. Lemire, J. M., C. K. Chan, S. Bressler, J. Miller, R. G. LeBaron, and T. N. Wight. 2007. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells. J. Cell. Biochem. 101:753-766.
48. Li, Y., S. Lee, T. Langleite, F. Norheim, S. Pourteymour, J. Jensen, et al. 2014. Subsarcolemmal lipid droplet responses to a combined endurance and strength exercise intervention. Physiol. Rep. 2: doi: 10.14814/phy2.12187.
49. Lieber, R. L., and S. R. Ward. 2013. Cellular mechanisms of tissue fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis. Am. J. Physiol. Cell Physiol. 305: C241-C252.
50. Lindahl, U., and J. P. Li. 2009. Interactions between heparan sulfate and proteins-design and functional implications. Int. Rev. Cell Mol. Biol. 276:105-159.
51. Lund, D. K., and D. D. Cornelison. 2013. Enter the matrix: shape, signal and superhighway. FEBS J. 280:4089-4099.
52. Meen, A. J., I. Oynebraten, T. M. Reine, A. Duelli, K. Svennevig, G. Pejler, et al. 2011. Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J. Biol. Chem. 286:2636-2647.
53. Melo, F., and E. Brandan. 1993. Decorin is specifically solubilized by heparin from the extracellular matrix of rat skeletal muscles. FEBS Lett. 319:249-252.
54. Naba, A., K. R. Clauser, S. Hoersch, H. Liu, S. A. Carr, and R. O. Hynes. 2012. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell Proteomics 11:M111.014647.
55. Niemann, C. U., M. Abrink, G. Pejler, R. L. Fischer, E. I. Christensen, S. D. Knight, et al. 2007. Neutrophil elastase depends on serglycin proteoglycan for localization in granules. Blood 109:4478-4486.
56. Norheim, F., T. Raastad, B. Thiede, A. C. Rustan, C. A. Drevon, and F. Haugen. 2011. Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am. J. Physiol. Endocrinol. Metab. 301:E1013-E1021.
57. Norheim, F., M. Hjorth, T. M. Langleite, S. Lee, T. Holen, C. Bindesboll, et al. 2014. Regulation of angiopoietin-like protein 4 production during and after exercise. Physiol. Rep. 2: doi: 10.14814/phy2.12109.
58. Pejler, G., J. O. Winberg, T. T. Vuong, F. Henningsson, L. Uhlin-Hansen, K. Kimata, et al. 2003. Secretion of macrophage urokinase plasminogen activator is dependent on proteoglycans. Eur. J. Biochem. 270:3971-3980.
59. Purushothaman, A., and B. P. Toole. 2014. Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization. J. Biol. Chem. 289:5499-5509.
60. Reine, T. M., T. T. Vuong, T. G. Jenssen, and S. O. Kolset. 2014. Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro. Biochim. Biophys. Acta 1840:2498-2505.
61. Robinson, M. D., D. J. McCarthy, and G. K. Smyth. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139-140.
62. Robinson, J. T., H. Thorvaldsdottir, W. Winckler, M. Guttman, E. S. Lander, G. Getz, et al. 2011. Integrative genomics viewer. Nat. Biotechnol. 29:24-26.
63. Schick, B. P., J. F. Gradowski, and J. D. San Antonio. 2001. Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells. Blood 97:449-458.
64. Serrano, A. L., and P. Munoz-Canoves. 2010. Regulation and dysregulation of fibrosis in skeletal muscle. Exp. Cell Res. 316:3050-3058.
65. Skliris, A., V. T. Labropoulou, D. J. Papachristou, A. Aletras, N. K. Karamanos, and A. D. Theocharis. 2013. Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases. FEBS J. 280:2342-2352.
66. Sparks, L. M., C. Moro, B. Ukropcova, S. Bajpeyi, A. E. Civitarese, M. W. Hulver, et al. 2011. Remodeling lipid metabolism and improving insulin responsiveness in human primary myotubes. PLoS ONE 6:e21068.
67. Stevens, R. L., K. Otsu, and K. F. Austen. 1985. Purification and analysis of the core protein of the protease-resistant intracellular chondroitin sulfate E proteoglycan from the interleukin 3-dependent mouse mast cell. J. Biol. Chem. 260:14194-14200.
68. Szklarczyk, D., A. Franceschini, S. Wyder, K. Forslund, D. Heller, J. Huerta-Cepas, et al. 2015. STRING v10: proteinprotein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43:D447-D452.
69. Tabas, I., K. J. Williams, and J. Boren. 2007. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116:1832-1844.
70. Timmons, J. A., O. Larsson, E. Jansson, H. Fischer, T. Gustafsson, P. L. Greenhaff, et al. 2005. Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J. 19:750-760.
71. Trayhurn, P., C. A. Drevon, and J. Eckel. 2011. Secreted proteins from adipose tissue and skeletal muscle-adipokines, myokines and adipose/muscle cross-talk. Arch. Physiol. Biochem. 117:47-56.
72. Velleman, S. G., R. A. Patterson, and K. E. Nestor. 1997. Identification of decorin and chondroitin sulfate proteoglycans in turkey skeletal muscle. Poult. Sci. 76:506-510.
73. Waern, I., I. Karlsson, M. Thorpe, S. M. Schlenner, T. B. Feyerabend, H. R. Rodewald, et al. 2012. Mast cells limit extracellular levels of IL-13 via a serglycin proteoglycanserine protease axis. Biol. Chem. 393:1555-1567.
74. Wernersson, S., and G. Pejler. 2014. Mast cell secretory granules: armed for battle. Nat. Rev. Immunol. 14:478-494.
75. Winberg, J. O., S. O. Kolset, E. Berg, and L. Uhlin-Hansen. 2000. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J. Mol. Biol. 304:669-680.
76. Wood, L. K., E. Kayupov, J. P. Gumucio, C. L. Mendias, D. R. Claflin, and S. V. Brooks. 2014. Intrinsic stiffness of extracellular matrix increases with age in skeletal muscles of mice. J. Appl. Physiol. (1985) 117:363-369.
77. Worzfeld, T., and S. Offermanns. 2014. Semaphorins and plexins as therapeutic targets. Nat. Rev. Drug Discov. 13:603-621.
78. Yan, Z., M. Okutsu, Y. N. Akhtar, and V. A. Lira. 2011. Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle. J. Appl. Physiol. (1985) 110:264-274.
79. Zernichow, L., M. Abrink, J. Hallgren, M. Grujic, G. Pejler, and S. O. Kolset. 2006. Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide. J. Biol. Chem. 281:26792-26801.
80. Zhang, L., M. Yang, D. Yang, G. Cavey, P. Davidson, and G. Gibson. 2010. Molecular interactions of MMP-13 Cterminal domain with chondrocyte proteins. Connect. Tissue Res. 51:230-239.